Concord Drugs Ltd.

Financial

	Concord Drugs	Veerhealth Care	Unick Fix-A-Form
Operational Metrics
Financials
5 yr Average ROE	3.38 %	2.69 %	9.15 %
5yr average Equity Multiplier	1.86	1.31	2.49
5yr Average Asset Turnover Ratio	0.9	0.54	0.88
5yr Avg Net Profit Margin	1.88 %	4.02 %	4.16 %
Price to Book	0.94	1.35	1.02
P/E	94.64	76.62	13.51
5yr Avg Cash Conversion Cycle	260.53 Days	80.55 Days	21.15 Days
Inventory Days	138.17 Days	54.84 Days	48.34 Days
Days Receivable	144.77 Days	79.49 Days	79.56 Days
Days Payable	77.93 Days	58.93 Days	119.31 Days
5yr Average Interest Coverage Ratio	1.8	208.32	2.62
5yr Avg ROCE	8.9 %	4.25 %	12.8 %
5yr Avg Operating Profit Margin	9.09 %	0.98 %	14.14 %
5 yr average Debt to Equity	0.55	0.06	0.86
5yr CAGR Net Profit	-21.63 %	5.08 %	-7.47 %
5yr Average Return on Assets	1.77 %	2.18 %	3.64 %
Shareholdings
Promoter Holding	54.39 %	31.5 %	71.57 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	5.39 %	-10.84 %	35.92 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0